Cancer Research and Treatment10.4143/crt.2018.2502019512685-695Reduction of Target Volume and the Corresponding Dose for the Tumor Regression Field after Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal CarcinomaLei Wang, Zheng Wu, Dehuan Xie, Ruifang Zeng, Wanqin Cheng, Jiang Hu, Shaomin Huang, Shu Zhou, Rui Zhong, Yong Su,,
Cancer/Radiothérapie10.1016/s1278-3218(02)00194-4200265334-335Patterns of failure after induction chemotherapy and radiotherapy for locoregionally advanced nasopharyngeal carcinoma: the Queen Mary Hospital experienceS Vignot, G Noël, J.J Mazeron,
Head & Neck10.1002/hed.2562020194161863-1872The prognostic value of volumetric reduction of the target lesions after induction chemotherapy in locoregionally advanced nasopharyngeal carcinomaZhong‐zheng Xiang, Fang Liu, Ruo‐nan Yan, Yuan‐yuan Zeng, Tao He, Zhen Zeng, Zhi‐hui Zhu, Long Bai, Jia‐chun Ma, Lei Liu,,,
International Journal of Radiation Oncology*Biology*Physics10.1016/j.ijrobp.2020.07.29020201083e803Nutritional Results After Target Volume Reduction Of Intensity-Modulated Radiotherapy Following Induction Chemotherapy In Locoregionally Advanced Nasopharyngeal Cancer: A Phase 3, Multicenter, Randomized Controlled TrialL. Xiang, J. Wu,
International Journal of Radiation Oncology*Biology*Physics10.1016/j.ijrobp.2019.06.41420191051S18Four-Year Outcome after Reduction of the Target Volume of Intensity Modulated Radiotherapy Following Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase III, Multicentre, Randomised Controlled TrialL. Xiang, J. Wu, H. Yang, S. Lin, J. Zhang, Q. Wen, P. Ren, H. Pang,
10.21203/ Acute Injury of Intensity-Modulated Radiotherapy vs. Three-Dimensional Conformal Radiotherapy in Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma: A Prospective Cohort Study,
Cancer Communications10.1186/s40880-019-0385-5201939139Induction gemcitabine and cisplatin in locoregionally advanced nasopharyngeal carcinomaYuan Zhang, Ying Sun, Jun Ma,,,,
Cancer10.1002/1097-0142(19981201)83:11<2255::aid-cncr4>;2-#199883112255-2258Is chemotherapy beneficial in the treatment of locoregionally advanced nasopharyngeal carcinoma?James R. Wong;2-#,;2-#
Clinical Oncology10.1016/j.clon.2012.07.0152013253162-170Target Volume Definition for Intensity-modulated Radiotherapy after Induction Chemotherapy and Patterns of Treatment Failure after Sequential Chemoradiotherapy in Locoregionally Advanced Oropharyngeal Squamous Cell CarcinomaS.W. Loo, K. Geropantas, P. Wilson, W.M.C. Martin, T.W. Roques,
International Journal of Radiation Oncology*Biology*Physics10.1016/j.ijrobp.2020.07.36220201083e833The Comparison of Prognostic Value of Volumetric Regression Ratio and RECIST 1.1 Criteria of the Primary Tumor and Metastatic Lymph Nodes after Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal CarcinomaY.Y. Zeng, Z.Z. Xiang, T. He, F. Liu, B.F. Shao, R.N. Yan, J.C. Ma, X.R. Wang, L. Zeng, L. Liu,